By Kevin Doherty

You sat down at the kitchen table on a Saturday morning to do the math on what the practice actually earned last year. The number on the tax return said $94,000 net income. You’d seen 287 active patients across the year, completed approximately 1,100 visits, dispensed something in the neighborhood of $45,000 in supplements through the online dispensary. The number sounded okay until you actually divided it by the hours you’d worked. 47 weeks at roughly 50 hours per week including charting, between-visit messaging, supplement order management, and the administrative work that wasn’t billable. $40 per hour, working harder than during clinical rotations as a student, four years out from the credential and seven years out from the financial obligations of naturopathic medical school. The math wasn’t sustainable.

You’d set the pricing back when you opened the practice. Initial consultation $200. Follow-ups $125. Package pricing felt aggressive at the time — you’d offered a few three-month protocol packages but most patients had paid visit-by-visit. The supplement dispensary was modest because you’d been worried about the optics of “supplement selling” and had kept your recommendations conservative. Three years in, you’d raised follow-ups to $150 and added a $1,200 three-month protocol package that some patients chose. The revenue had grown but the hours per dollar hadn’t shifted meaningfully. You were still working at the same hourly rate, just with more patients now occupying the same hours.

This is the most common pricing pattern in ND practice and the structural limit that keeps most NDs in the $80K-$150K income band the AANMC graduate compensation studies document. The pricing decisions made in the first year of practice get locked in psychologically and operationally. Raising prices feels confrontational. Adding package structure feels manipulative. Building deliberate supplement dispensing infrastructure feels mercenary. The cumulative effect of these hesitations is practice economics constrained well below what the actual clinical work warrants. The NDs in the top quartile of income aren’t doing meaningfully different clinical work than the NDs in the middle. They’re operating with deliberate pricing architecture rather than default pricing assumptions.

This article covers ND pricing in operational depth. The four pricing tiers that work for ND practices. Initial consultation, follow-up, and package pricing structure. The supplement dispensing economics that account for 20-40% of total ND practice revenue when built deliberately. Insurance billing integration in licensed states where applicable. The internal work that determines whether NDs can actually hold the pricing their practices can sustain rather than collapsing back to defensive pricing assumptions. The pricing layer is the third of the six covered at the naturopathic medicine practice growth hub.

Why Most ND Practices Underprice

The pattern of ND underpricing is consistent enough across the profession that it warrants direct examination. AANMC graduate compensation studies and industry surveys consistently show ND income clustering in the $80K-$150K band with a long tail of higher-earning practitioners. The income gap between median and top-quartile NDs isn’t primarily about clinical capability — most NDs in the profession are clinically capable. The gap is about pricing architecture and the willingness to hold pricing that matches actual clinical scope.

Three structural factors produce the underpricing pattern.

The pricing decision happens before practice authority is established. Most NDs set initial pricing in the foundation phase of practice — before patient outcomes have demonstrated clinical value, before content marketing has established authority, before the practice has reputation in its local market. The natural psychological move at this point is conservative pricing that “matches what NDs charge in this area.” That benchmark gets locked in and becomes psychologically difficult to revise upward as authority develops.

The income comparison creates anchoring effects. ND education programs often communicate income expectations in the $80K-$150K range based on AANMC graduate data. The data is accurate but the framing affects pricing decisions — NDs internalize that range as the realistic income ceiling and price accordingly. NDs in the top quartile (earning $200K+) typically arrive at that income through deliberate pricing architecture that doesn’t accept the median as the ceiling.

The supplement dispensing ethics concern produces deliberately conservative dispensing. Many NDs reduce supplement recommendations or avoid building dispensing infrastructure out of concern about appearing to “sell supplements” rather than provide clinical care. The concern is real and worth navigating thoughtfully. The result for many practices, however, is that the supplement dispensing revenue that should account for 20-40% of total practice income accounts for 5-15%, leaving substantial revenue on the table that could come from supplements the patients are buying anyway from less-trusted sources.

The combined effect across these three factors is ND practice economics constrained well below what the clinical work supports. The cross-applied dynamics in adjacent FM practitioner contexts are covered in the NFM pricing spoke; the underlying psychology shows up similarly across both populations.

The Four Pricing Tiers

Four pricing tiers within ND practice each serve different patient populations and operate with different economics. The decision among them depends on sub-niche from the positioning spoke, regulatory environment from the state licensure spoke, geographic market, and practitioner authority.

Foundation tier ($150-$250 initial consultation, $100-$150 follow-ups)

The entry tier for new ND practices establishing initial positioning, practices in less affluent geographies, or unlicensed-state practices with significant scope constraints. Typical at this tier: generalist or new-specialty positioning, 200-300 active patients possible due to lower price point allowing larger panels, supplement dispensing revenue often becomes proportionally larger relative to consultation revenue.

Patient profile: middle-income to upper-middle-income individuals seeking integrative care without paying premium tier fees. Often patients new to naturopathic care who haven’t yet experienced the value depth that supports premium pricing.

Practice economics: 250-member panel at $200 average consultation revenue, ~6 visits annually = $300K consultation revenue. Add 30% supplement dispensing = $90K = total revenue $390K. After 40% overhead, physician compensation around $230K — adequate but not strong relative to the volume of work.

Best fit for: new ND launches building toward higher tiers, unlicensed-state practices with constrained scope, NDs in geographic markets with limited patient income capacity.

Standard tier ($250-$400 initial consultation, $150-$250 follow-ups)

The working tier for most established ND practices in licensed states with clear sub-niche positioning. Typical at this tier: defined sub-niche specialty positioning, 150-250 active patients, consultation cadence appropriate to specialty work (6-12 visits annually for active protocols, less for maintenance patients).

Patient profile: upper-middle-income professionals, families with substantial healthcare spending, patients with specific clinical situations requiring depth. Many use HSA/FSA for portions of consultation costs where eligible. Some have insurance coverage they can apply to portions of services in licensed states.

Practice economics: 200-member panel at $300 average consultation = $600K consultation revenue annually with 10 visits per active patient. Add 30% supplement dispensing = $180K = total revenue $780K. After 40% overhead, physician compensation around $470K — strong relative to typical ND income data, suggesting most “Standard tier” NDs are actually pricing below this tier.

Realistic adjustment for typical Standard tier practice: smaller panels of 130-180 active patients with 8-10 visits annually = $400K-$540K consultation revenue. Add supplement dispensing = $520K-$700K total revenue. After 40% overhead, $310K-$420K compensation. Still substantially above typical ND income data, suggesting that even Standard tier pricing executed deliberately produces meaningfully better economics than typical ND income surveys suggest.

Best fit for: established ND practices with clear sub-niche positioning, licensed state environment, patient population willing to pay specialty rates.

Specialty tier ($400-$600 initial consultation, $250-$400 follow-ups)

The tier for practices with established specialty authority. Typical at this tier: women’s health and hormones with established positioning, mental health specialty, established autoimmune or fertility practices, primary care ND in highest-income geographies. Panel sizes typically 100-170 active patients. Service depth substantially expanded — comprehensive workups, longer visits, more between-visit communication.

Patient profile: high-income professionals, patients seeking established specialty depth, often patients with complex chronic conditions or substantial longevity-focus interest. Annual healthcare spending typically $20K-$50K across all sources, making the practice’s pricing meaningful but acceptable.

Practice economics: 130-member panel at $400 average consultation = $520K consultation revenue with 10 visits per active patient. Add 35% supplement dispensing = $182K = total revenue $702K. After 40% overhead, physician compensation around $420K.

Best fit for: practices with established specialty positioning (typically 3+ years operating), strong content marketing producing acquisition, patient demographics capable of paying specialty rates.

Premium specialty tier ($600-$1,000+ initial consultation, $400-$600+ follow-ups)

The top tier of ND practice, serving 80-150 patients with comprehensive integrated specialty care. Typical at this tier: FABNO-certified naturopathic oncology, premium-positioned women’s health (often hormone replacement therapy specialty), executive-level integrative practices, ND practices serving high-net-worth populations with longevity focus.

Patient profile: high-net-worth individuals, executives, patients with complex chronic conditions requiring intensive specialty support. Annual healthcare spending typically exceeds $50K across all sources. The pricing reflects substantial scope — extensive testing, intensive protocol customization, frequent communication, sometimes longer visits or in-home care arrangements.

Practice economics: 100-member panel at $700 average consultation = $560K consultation revenue with 8 visits per active patient. Add 40% supplement dispensing = $224K = total revenue $784K. After 40% overhead, physician compensation around $470K.

Best fit for: NDs with substantial established authority (typically 5+ years operating in specialty), willingness to operate at the highest tier of clinical service expectations, patient population fit for premium pricing. Naturopathic oncology with FABNO is the most common pathway to this tier.

Package Pricing for Chronic Conditions

Beyond visit-by-visit pricing, package pricing for chronic condition protocols substantially expands per-patient revenue and typically improves clinical outcomes. The mechanics matter.

Most chronic conditions ND practices treat — autoimmune, hormonal balance, gut healing, fertility preparation, mental health — require sustained protocol work over 3-6 months minimum. Patients paying visit-by-visit often discontinue care prematurely when symptoms partially resolve, leaving the underlying patterns insufficiently addressed. Package pricing aligns financial commitment with clinical timeline.

Standard package structures

3-month protocol packages. Typically $1,500-$3,500 covering initial consultation, comprehensive workup, 3-4 follow-up visits, ongoing protocol adjustment, between-visit messaging support. Common for hormonal balance, mental health, autoimmune onboarding.

6-month protocol packages. Typically $3,000-$5,500 covering 6-8 visits plus intake and ongoing support. Common for autoimmune deep work, fertility preparation, complex hormone work, gut healing protocols.

12-month maintenance packages. Typically $4,500-$8,000 for ongoing care relationships after initial protocol completion. Less common but valuable for patients establishing long-term ND relationships for ongoing health management.

Specialty oncology packages. FABNO-certified naturopathic oncology often uses different package structures matched to cancer treatment phases — pre-treatment optimization, active treatment support, post-treatment recovery — typically $4,000-$10,000+ depending on cancer type and treatment intensity.

Package pricing math

The math typically prices packages at 10-20% discount from visit-by-visit pricing for the same number of visits. The discount creates the financial incentive that motivates package commitment without sacrificing per-patient revenue. For example: 6 visits at $300 visit-by-visit pricing = $1,800. Package pricing at $1,500-$1,650 represents 8-17% discount that incentivizes commitment.

The economic case for packages: patients who commit to packages typically complete the full protocol (90%+ completion rates vs. 50-70% completion for visit-by-visit patients), produce better clinical outcomes (which generates referrals), and consume less administrative time (no per-visit payment processing, scheduling friction reduced). The slight per-visit revenue reduction is more than offset by completion rate improvement and reduced friction.

Implementation considerations

Packages should be presented during initial consultations as the standard option for the patient’s specific situation, not as upsell. Visit-by-visit remains available for patients who prefer it but isn’t positioned as the default. The framing affects conversion substantially — packages presented as “the standard way patients in your situation work with us” convert at 55-75%; packages presented as upgrade option convert at 25-40%.

Payment timing for packages: most successful practices offer single-payment (sometimes with small discount) or 2-3 installment payment options. Monthly payments across the package timeline produce higher conversion but more administrative complexity. The full conversion architecture for package presentation is in the consultation conversion spoke.

Supplement Dispensing Economics

Supplement dispensing accounts for 20-40% of total revenue in well-built ND practices. Understanding the economics directly affects practice viability.

The dispensing math

Typical supplement margins: 15-30% on online dispensary platforms (Fullscript, Wellevate, Emerson), 30-60% on in-office direct purchasing, 20-40% on hybrid models. Patients in active protocol typically spend $80-$300 monthly on supplements. The cumulative dispensing revenue at standard tier practice with 200 active patients spending average $150 monthly = $360K annually with 30% margin = $108K margin contribution.

For specialty tier practice with 130 active patients spending $200 monthly = $312K annually with 35% margin = $109K margin contribution. The dispensing revenue often equals 25-45% of total physician compensation in well-built practices.

If you’re not sure whether your supplement dispensing infrastructure is producing the revenue it should, the AI Discovery Framework includes pricing and revenue model assessment in the 12-minute diagnostic.

Online dispensary platforms

Fullscript. The largest professional supplement platform. Margins typically 15-25% with patient discount structure. Patients order direct from Fullscript with practitioner protocol guidance. No inventory burden for the practice. Substantial supplement catalog.

Wellevate. Comparable to Fullscript with similar economics. Some practitioners prefer one over the other based on specific catalog or interface preferences.

Emerson Ecologics. Another major professional supplement distributor. Some practices use Emerson for direct ordering and offer patients access through practice-specific accounts.

Direct manufacturer accounts. Some practices establish direct accounts with major supplement manufacturers (Designs for Health, Pure Encapsulations, Thorne, Metagenics, others) for in-office dispensing or for specific products. Margins are higher but inventory management and minimum order requirements create overhead.

In-office vs. online dispensary structure

In-office dispensing typically produces higher margins (30-60%) but requires inventory investment, retail space, supplement management infrastructure, and shorter shelf-life management. Works well for practices with consistent patient flow and physical office space, especially for high-turnover supplements.

Online dispensary typically produces lower margins (15-25%) but eliminates inventory burden, scales infinitely, supports telehealth-primary practices, and provides patients access to substantially larger supplement catalogs than in-office can offer.

Hybrid models combine in-office for high-turnover items (commonly used probiotics, basic multivitamins, specific frequently-dispensed protocols) with online dispensary for the broader supplement library. Most successful ND practices use hybrid approaches.

The ethics framing

The ethics of supplement dispensing deserves direct treatment because practitioner discomfort here creates the underdispensing pattern that constrains many ND practices economically.

The honest framing: patients with chronic conditions are buying supplements regardless of where they purchase them. The patients buying supplements at retail without practitioner guidance often buy lower-quality products at higher prices than practitioner-dispensed alternatives. The patients buying supplements through practitioner guidance get quality assurance, protocol coherence, and dosing appropriate to their specific clinical situation. The dispensing isn’t extracting revenue from patients; it’s providing a service the patients need at quality the patients can’t easily evaluate independently.

The unethical version of supplement dispensing — recommending unnecessary products to expand practice revenue, dispensing at inflated prices, prioritizing supplement margin over patient outcome — is what practitioners worry about when they hesitate around dispensing. The ethical version — recommending appropriate supplements at fair prices through transparent dispensary infrastructure — is genuinely good for both patient and practice. The discomfort that produces underdispensing usually conflates the two and constrains the ethical version unnecessarily.

NDs who navigate this thoughtfully build dispensing infrastructure deliberately, communicate transparently with patients about how the dispensary works, recommend supplements appropriate to clinical situations rather than to revenue targets, and let the dispensing revenue settle at whatever level appropriate clinical guidance produces. The result is typically the 20-40% revenue contribution that healthy ND practice economics depend on.

Insurance Billing Integration in Licensed States

Licensed states with insurance parity laws or favorable insurance carrier participation make insurance billing viable for primary care ND practices. The integration with cash-pay structure determines practice economics.

The hybrid revenue structure

Most successful licensed-state primary care ND practices integrate insurance billing for medical services with cash-pay structure for time-intensive consultations and naturopathic treatment work. The structure typically separates revenue streams:

Insurance-billed services: standard medical visits, diagnostic ordering, basic primary care work covered by insurance. Reimbursement rates typically lower than cash-pay rates for equivalent time but supplement revenue base.

Cash-pay services: initial comprehensive consultations (often 60-90 minutes, beyond what insurance reimburses), specialty protocol work, supplement dispensing, time-intensive between-visit messaging support. Patients pay directly.

Hybrid services: some visits where insurance is billed for the medical components and patient pays cash for additional time or specific naturopathic services beyond insurance scope.

Insurance billing infrastructure considerations

Insurance billing requires specific infrastructure: credentialing with insurance carriers (typically 60-120 days per carrier), billing software or service, denial management capability, contract negotiation for reimbursement rates, ongoing administrative support for billing questions.

Most practices benefit from outsourcing insurance billing to specialized service rather than handling in-house. ND-specific billing services exist; some practices use general medical billing services with ND scope familiarity. Costs typically 5-8% of insurance-billed revenue, which is meaningful but typically less than the practice cost of handling in-house.

The decision to bill insurance

Not all licensed-state ND practices benefit from insurance billing. The decision factors:

Patient population fit. Primary care ND practices serving general adult populations benefit substantially from insurance access (expands acquisition). Specialty ND practices serving sub-niche-specific populations often don’t benefit because the specialty work exceeds insurance reimbursement support anyway.

Geographic insurance landscape. States and metros with strong ND insurance parity (Washington, Oregon) make billing meaningful. States with weak parity make billing administratively burdensome relative to revenue contribution.

Practice scope fit. Primary care positioning supports insurance billing. Specialty consultation positioning often doesn’t because the consultation time exceeds reimbursement support regardless of insurance access.

The decision benefits from analysis of the specific local insurance landscape and the specific practice’s patient population needs. Licensed-state practices specifically positioned as primary care typically benefit from insurance billing; licensed-state specialty practices often don’t.

The Internal Work Behind Pricing Decisions

Underneath most ND pricing that’s set too low is a specific pattern of practitioner discomfort that deserves explicit naming. The pattern shows up in several common forms.

“My patients can’t afford more than $X.” The empathy framing. Sincere, often inaccurate. The patients who can afford ND specialty care at any price point typically have substantial healthcare spending across many sources. The consultation fee is rarely the binding financial constraint. Patients who genuinely can’t afford the practice will self-select out regardless of price; patients who can afford it typically don’t notice the difference between $200 and $400 consultations because both fit within their broader healthcare budget.

“I’m not sure my work is worth that much.” The imposter framing. Most common and least named explicitly. The ND with five years of established clinical experience, strong patient outcomes, and specialty depth — and still doesn’t quite believe her work is worth what comparable practitioners charge. This belief is almost always inaccurate on the facts. It is also almost always the controlling factor in pricing decisions regardless of strategic arguments for premium pricing.

“NDs don’t typically charge that much.” The norm anchoring. The argument that pricing should match what other NDs charge in the area. This argument confuses descriptive (what NDs charge) with prescriptive (what NDs should charge given their clinical work). The fact that most NDs underprice doesn’t argue for additional underpricing; it argues for the practitioner who breaks the pattern to claim economic advantage.

“What if patients leave when I raise prices?” The fear framing. Real concern, mitigated by data. Industry retention data on price increases typically shows 85-95% retention through well-communicated 15-25% increases. The 5-15% who leave are typically members for whom the practice wasn’t strong fit anyway. The retention through transitions is substantially better than the practitioner’s anxiety predicts.

The self-aware practitioner’s imposter syndrome piece covers this dynamic in detail. The form it takes in ND pricing specifically: the practitioner reflexively imagines that pricing above some safe baseline is exploiting patients or overreaching her own value, when in fact the math strongly supports higher pricing and the patients themselves typically signal acceptance through actions (joining, referring, completing protocols) rather than through pricing pushback.

The move through this dynamic is consistent. Set pricing at the level the practice’s actual scope supports rather than the level that feels safe. Hold pricing through introductory consultations without flinching. Watch practice economics respond. The discomfort doesn’t resolve through theoretical preparation; it resolves through repeated experience of patients accepting pricing the practitioner privately worried was too high. The Practitioner’s Dilemma names the underlying tension this surfaces.

What Pricing Set Correctly Produces

NDs who move from underpriced to correctly priced — typical transition from $200 initial / $125 follow-up to $350 initial / $225 follow-up or similar adjustments — typically show specific patterns over 12-24 months.

Average revenue per patient roughly doubles. Patient count typically decreases 10-20% (the 10-20% who weren’t strong fits leave). Total practice revenue typically increases 1.5-1.8x because the per-patient increase outweighs the modest patient attrition. Time per remaining patient often increases as smaller panels allow more clinical attention. Practitioner compensation typically increases 60-100%.

Patient quality at the consultation stage typically improves because the higher fee filters for prospective patients with stronger commitment and clearer fit for specialty work. Conversion through consultations often improves rather than degrades because the prospective patients arriving at higher pricing are more aligned with the practice’s specialty positioning.

The pattern is consistent across practices making correct pricing transitions. The initial pricing change feels risky. The actual downstream effects are substantially positive for both practice economics and clinical work quality. NDs who hold pricing at the level their actual scope supports — and resist the discomfort that wants to set it lower — operate practices that compound substantially differently than practices that set pricing at the safe-feeling level.

Frequently Asked Questions